List view / Grid view

News

NDA for aripiprazole depot formulation for maintenance treatment of adult patients with schizophrenia accepted

22 November 2011 | By H. Lundbeck A/S (Lundbeck)

H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced today that the US Food and Drug Administration (FDA) has determined that a new drug application (NDA) for Otsuka's investigational once-monthly aripiprazole depot formulation for the indication of maintenance treatment of schizophrenia in adults is sufficiently complete to permit…

Sunrise™ in Mongolia

22 November 2011 | By kdm communications limited

Donation of a Tecan Sunrise™ microplate reader to Mongolian medical researchers, assisting their studies of vitamin D levels in the general population...